Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sarah M. Weenink"'
Autor:
Michael R. Christie, Patricia A. McKinney, Rossitza Ananieva-Jordanova, J. Lo, Jadwiga Furmaniak, J. M. Tremble, Charlotte Stephenson, H. J. Bodansky, Sarah M. Weenink, B. Rees Smith
Publikováno v:
Journal of Autoimmunity. 33:147-154
B-cells influence T-cell reactivity by facilitating antigen presentation, but the role of autoantibody-secreting B-cells in regulating T-cell responses in Type 1 diabetes is poorly defined. The aims of this study were to characterise epitopes on the
Autor:
Josef Endl, James A. Dromey, Sarah M. Weenink, Michael R. Christie, Ian Todd, Patrick J. Tighe, Günther H.J. Peters
Publikováno v:
ResearcherID
IA-2 is a major target of autoimmunity in type 1 diabetes. IA-2 responsive T cells recognize determinants within regions represented by amino acids 787–817 and 841–869 of the molecule. Epitopes for IA-2 autoantibodies are largely conformational a
Publikováno v:
Journal of Biological Chemistry. 278:2969-2976
Insulin-like growth factor-binding protein-3 (IGFBP-3) is inhibitory to the growth of many breast cancer cells in vitro; however, a high level of expression of IGFBP-3 in breast tumors correlates with poor prognosis, suggesting that IGFBP-3 may be as
Publikováno v:
Veterinary immunology and immunopathology. 126(1-2)
Diabetes mellitus in dogs shares many characteristics with the human type 1 disease and virtually all diabetic dogs require insulin therapy to control hyperglycaemia. Insulin deficiency is suspected to result from immune-mediated destruction of pancr
Autor:
Sarah M. Weenink, Michael R. Christie
Publikováno v:
Autoantibodies and Autoimmunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e779d889259924eb1f44e9aa6ca3a032
https://doi.org/10.1002/3527607854.ch15
https://doi.org/10.1002/3527607854.ch15
Publikováno v:
The Journal of biological chemistry. 278(5)
Insulin-like growth factor-binding protein-3 (IGFBP-3) is inhibitory to the growth of many breast cancer cells in vitro; however, a high level of expression of IGFBP-3 in breast tumors correlates with poor prognosis, suggesting that IGFBP-3 may be as